Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | CNR1 | P21554 | 1/20 | 0.57 |
| ▸ | CNR2 | P34972 | 1/20 | 0.57 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.51 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.51 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11877146 | 1.00 | ALDH1A1 (0.57) | ALDH1A1CNR1CNR2LPAR2LPAR3 | |
| SCHEMBL10882065 | 0.88 | DNM1 (0.50) | LPAR2LPAR3LPAR1 | |
| SCHEMBL10878345 | 0.88 | DNM1 (0.50) | LPAR2LPAR3LPAR1 | |
| SCHEMBL28358020 | 0.88 | DNM1 (0.50) | LPAR2LPAR3LPAR1 | |
| SCHEMBL1096441 | 0.88 | DNM1 (0.50) | LPAR2LPAR3LPAR1 | |
| SCHEMBL5537012 | 0.88 | DNM1 (0.50) | LPAR2LPAR3LPAR1 | |
| SCHEMBL6945069 | 0.88 | DNM1 (0.50) | LPAR2LPAR3LPAR1 | |
| SCHEMBL10880891 | 0.88 | DNM1 (0.50) | LPAR2LPAR3LPAR1 | |
| SCHEMBL1095622 | 0.88 | DNM1 (0.50) | LPAR2LPAR3LPAR1 | |
| SCHEMBL2548513 | 0.88 | DNM1 (0.50) | LPAR2LPAR3LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12594292-B2 | Antiviral prodrugs, intermediate-and long-acting formulations and methods | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-04-07 | — | — | US | disclosed |
| US-20250177428-A1 | ANTIVIRAL PRODRUGS, INTERMEDIATE-AND LONG-ACTING FORMULATIONS AND METHODS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-06-05 | — | — | US | disclosed |
| WO-2024159117-A1 | ANTIVIRAL PRODRUGS, INTERMEDIATE-AND LONG-ACTING FORMULATIONS, AND METHODS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-08-02 | — | — | WO | disclosed |
| US-20100286151-A1 | 1-OXA-3-Azaspiro[4,5]Decan--2-One Derivatives For The Treatment Of Eating Disorders | BENTLEY JONATHAN | 2010-11-11 | — | — | US | disclosed |
| US-3933733-A | Phosphite stabilized polyvinyl chloride containing resins | KYODO CHEMICAL COMPANY, LIMITED (JA) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12594292-B2 | Antiviral prodrugs, intermediate-and long-acting formulations and methods | ACE2, SARS1, FURIN | ALDH1A1 4279/4885CNR1 2852/4885CNR2 1886/4885 |
| US-20250177428-A1 | ANTIVIRAL PRODRUGS, INTERMEDIATE-AND LONG-ACTING FORMULATIONS AND METHODS | SARS1, ACE2, FURIN | ALDH1A1 3768/4885CNR1 1769/4885CNR2 1566/4885 |
| US-20100286151-A1 | 1-OXA-3-Azaspiro[4,5]Decan--2-One Derivatives For The Treatment Of Eating Disorders | NPY5R, NPY1R, NPY4R | ALDH1A1 3300/4885CNR1 11/4885CNR2 18/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.